Finance

Lists
2607:HKG
Shanghai Pharmaceuticals Holding Co Ltd
HK$11,17
-0,71%
(-0,080) 1D
16 ຕ.ລ., 16 ໂມງ 8 ນາທີ 14 ວິນາທີ GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2607...
Open
HK$11,29
High
HK$11,39
Low
HK$11,15
Mkt. cap
64,70 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
1,43 ລ້ານ
Dividend
4,67%
Quarterly dividend
HK$0,13
Ex-dividend date
18 ກ.ຍ. 2026
P/E ratio
7,40
52-wk high
HK$12,41
52-wk low
HK$10,70
EPS
HK$1,51
Shares outstanding
919,07 ລ້ານ
No. of employees
49 ພັນ
Open
HK$11,29
High
HK$11,39
Low
HK$11,15
Mkt. cap
64,70 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
1,43 ລ້ານ
Dividend
4,67%
Quarterly dividend
HK$0,13
Ex-dividend date
18 ກ.ຍ. 2026
P/E ratio
7,40
52-wk high
HK$12,41
52-wk low
HK$10,70
EPS
HK$1,51
Shares outstanding
919,07 ລ້ານ
No. of employees
49 ພັນ
News stories
From web sources and news partners
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holding Co Ltd
CEO-
Employees48,6 ພັນ
Founded18 ມ.ກ. 1994
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
73,48 ຕື້
68,51 ຕື້
75,26 ຕື້
72,21 ຕື້
Cost of goods sold
66,03 ຕື້
60,55 ຕື້
67,17 ຕື້
64,09 ຕື້
Cost of revenue
66,03 ຕື້
60,55 ຕື້
67,17 ຕື້
64,09 ຕື້
Research and development expenses
556,53 ລ້ານ
824,53 ລ້ານ
468,22 ລ້ານ
502,64 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,70 ຕື້
4,97 ຕື້
4,59 ຕື້
4,65 ຕື້
Operating expense
5,58 ຕື້
5,91 ຕື້
5,47 ຕື້
5,55 ຕື້
Total operating expenses
71,60 ຕື້
66,47 ຕື້
72,63 ຕື້
69,64 ຕື້
Operating income
1,88 ຕື້
2,04 ຕື້
2,63 ຕື້
2,57 ຕື້
Other non operating income
-84,84 ລ້ານ
-63,65 ລ້ານ
-47,88 ລ້ານ
-7,43 ລ້ານ
EBT including unusual items
1,48 ຕື້
1,52 ຕື້
2,42 ຕື້
3,21 ຕື້
EBT excluding unusual items
1,61 ຕື້
1,44 ຕື້
2,27 ຕື້
3,03 ຕື້
Income tax expense
485,91 ລ້ານ
534,14 ລ້ານ
569,09 ລ້ານ
720,64 ລ້ານ
Effective tax rate
32,89%
35,10%
23,52%
22,43%
Other operating expenses
129,62 ລ້ານ
271,29 ລ້ານ
132,16 ລ້ານ
186,62 ລ້ານ
Net income
688,20 ລ້ານ
577,49 ລ້ານ
1,42 ຕື້
2,09 ຕື້
Net profit margin
0,94%
0,84%
1,88%
2,89%
Earnings per share
-
-
-
-
Interest and investment income
206,57 ລ້ານ
-
38,70 ລ້ານ
873,52 ລ້ານ
Interest expense
-393,02 ລ້ານ
-470,36 ລ້ານ
-347,64 ລ້ານ
-358,39 ລ້ານ
Net interest expenses
-186,45 ລ້ານ
-470,36 ລ້ານ
-308,94 ລ້ານ
515,13 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
2,26 ຕື້
2,54 ຕື້
3,12 ຕື້
3,07 ຕື້
Gain or loss from assets sale
39,99 ລ້ານ
-157,15 ລ້ານ
-
-179,70 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google